DDX3X.md
... ...
@@ -2,6 +2,8 @@
2 2
bibliography: 'morinlab.bib'
3 3
csl: 'NLM.csl'
4 4
link-citations: true
5
+nocite: |
6
+ @mottokIntegrativeGenomicAnalysis2019, @schmitzBurkittLymphomaPathogenesis2012, @reddyGeneticFunctionalDrivers2017, @schmitzGeneticsPathogenesisDiffuse2018, @arthurGenomewideDiscoverySomatic2018
5 7
---
6 8
[[_TOC_]]
7 9
... ...
@@ -12,12 +14,7 @@ These mutations are predominantly loss-of-function (LOF) mutations, affecting th
12 14
13 15
## Relevance tier by entity
14 16
15
-|Entity|Tier|Description |
16
-|:------:|:----:|--------------------------------------|
17
-|![PMBL](images/icons/PMBL_tier1.png)|1|high-confidence PMBL/cHL/GZL gene[@mottokIntegrativeGenomicAnalysis2019]|
18
-|![BL](images/icons/BL_tier1.png) |1 | high-confidence BL gene [@schmitzBurkittLymphomaPathogenesis2012]|
19
-|![DLBCL](images/icons/DLBCL_tier1.png) |1 | high-confidence DLBCL gene [@reddyGeneticFunctionalDrivers2017; @schmitzGeneticsPathogenesisDiffuse2018; @arthurGenomewideDiscoverySomatic2018]|
20
-|![FL](images/icons/FL_tier2.png) |2 | Although recurrent, the relevance of mutations in FL is tenuous |
17
+[[include:table1_DDX3X]]
21 18
22 19
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
23 20